Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Dupixent
Dupixent
Rivals’ disappointing results in asthma trial drag down shares of Anaptys Bio
Stat
Fri, 06/21/19 - 10:00 am
Sanofi
Regeneron
IL-33
asthma
monoclonal antibodies
REGN3500
AnaptysBio
Dupixent
Mark Your Calendar For These June PDUFA Dates
Yahoo/Benzinga
Sat, 06/1/19 - 12:52 pm
FDA
Merck
Zerbaxa
XERIS
Gvoke HypoPen
Keytruda
Amag Pharmaceuticals
Palatin
Vyleesi
Acer Therapeutics
Edsivo
Sanofi
Regeneron
Dupixent
Alexion
Soliris
Retrophin
Thiola
Allergan
Botox
Go or no go? Merck, Regeneron and Alexion await US expansion
EP Vantage
Thu, 05/30/19 - 09:39 am
Merck
Keytruda
Sanofi
Regeneron
Dupixent
Alexion
Soliris
FDA
Dova Pharmaceuticals
Retrophin
FDA approves Dupixent for atopic dermatitis in adolescents
BioCentury
Mon, 03/11/19 - 10:15 pm
Dupixent
Regeneron
Sanofi
FDA
atopic dermatitis
Sanofi/Regeneron’s Dupixent shows more promise in nasal polyps
Pharmaforum
Tue, 02/26/19 - 11:48 pm
Sanofi
Regeneron
Dupixent
clinical trials
nasal polyps
7 drugs that raised eyebrows in Q3
Biopharma Dive
Thu, 11/15/18 - 11:50 pm
Sanofi
Dupixent
Roche
Herceptin
AbbVie
Humira
Regeneron
Repatha
Clovis Oncology
Rubraca
GSK
Shingrix
Eli Lilly
Trulicity
Going gangbusters in atopic dermatitis, the FDA hands Sanofi and Regeneron a fresh coup for their mega-blockbuster star Dupixent
Endpoints
Tue, 11/6/18 - 09:48 am
Sanofi
Regeneron
Dupixent
atopic dermatitis
Sanofi drug Dupixent wins U.S. FDA approval to treat asthma
Yahoo/Reuters
Fri, 10/19/18 - 10:49 pm
Sanofi
asthma
FDA
Dupixent
Regeneron, Sanofi talks up potential blockbuster franchise as Dupixent sweeps in rhinosinusitis PhIII
Endpoints
Tue, 10/16/18 - 11:44 am
Regeneron
Sanofi
Dupixent
nasal polyps
rhinosinusitis
Sanofi unveils eczema drug data, as regulators mull label expansion
Pharmaforum
Mon, 09/17/18 - 11:16 am
Sanofi
Dupixent
dupilumab
eczema
atopic dermatitis
Regeneron, Sanofi show restraint on Dupixent price hike, but Pfizer’s hard charge continues to spur calls for a radical change-up
Endpoints
Tue, 07/3/18 - 12:13 pm
Regeneron
Sanofi
Dupixent
drug pricing
Sanofi's Dupixent scores NICE recommendation after price cut
Fierce Pharma
Fri, 06/22/18 - 12:06 pm
Sanofi
NICE
atopic dermatitis
Dupixent
3 Reasons Regeneron Stock Could Start Climbing Again
Yahoo/Motley Fool
Sun, 05/6/18 - 01:14 pm
Sanofi
Regeneron
Praluent
Dupixent
Eylea
Sanofi blockbuster-to-be skin drug Dupixent fails to win gatekeeper's backing
Fierce Pharma
Tue, 04/3/18 - 10:59 pm
Sanofi
Dupixent
NICE
Sanofi and Regeneron's Dupixent launch is about to get a cash infusion
Fierce Pharma
Wed, 01/10/18 - 10:07 am
Sanofi
Regeneron
Dupixent
drug launches
eczema
JPMHC 2018
Regeneron-Sanofi food allergy drug succeeds mid-stage study
Yahoo/Reuters
Mon, 10/16/17 - 09:50 am
Regeneron
Amgen
food allergies
eosinophilic esophagitis
Dupixent
Sanofi and Regeneron, seeking to shield Dupixent, lose first IPR try against Amgen
Fierce Pharma
Thu, 10/5/17 - 09:34 am
Sanofi
Regeneron
Dupixent
IPR
Amgen
patents
Sanofi indicates dupilumab could be used to treat nasal polyps
Yahoo/Reuters
Wed, 09/13/17 - 09:35 am
Sanofi
dupilumab
Dupixent
nasal polyps
5 Things Regeneron's CEO Said as the Biotech Stock Sank
Motley Fool
Tue, 09/12/17 - 10:04 am
Regeneron
Pharma CEOs
Leonard Schleifer
Sanofi
Dupixent
Regeneron Touts Success in Big Asthma Drug Study, Plans FDA Filing
Xconomy
Mon, 09/11/17 - 09:33 am
Regeneron
asthma
FDA
Sanofi
Dupixent
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »